These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

517 related items for PubMed ID: 22494851

  • 41.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 42. Isolated pathogens and clinical outcomes of adult bacteremia in the emergency department: a retrospective study in a tertiary Referral Center.
    Kao CH, Kuo YC, Chen CC, Chang YT, Chen YS, Wann SR, Liu YC.
    J Microbiol Immunol Infect; 2011 Jun; 44(3):215-21. PubMed ID: 21524617
    [Abstract] [Full Text] [Related]

  • 43. Rapidly progressive fatal hemorrhagic pneumonia caused by Stenotrophomonas maltophilia in hematologic malignancy.
    Araoka H, Fujii T, Izutsu K, Kimura M, Nishida A, Ishiwata K, Nakano N, Tsuji M, Yamamoto H, Asano-Mori Y, Uchida N, Wake A, Taniguchi S, Yoneyama A.
    Transpl Infect Dis; 2012 Aug; 14(4):355-63. PubMed ID: 22283869
    [Abstract] [Full Text] [Related]

  • 44. Sphingomonas paucimobilis bacteremia in humans: 16 case reports and a literature review.
    Lin JN, Lai CH, Chen YH, Lin HL, Huang CK, Chen WF, Wang JL, Chung HC, Liang SH, Lin HH.
    J Microbiol Immunol Infect; 2010 Feb; 43(1):35-42. PubMed ID: 20434121
    [Abstract] [Full Text] [Related]

  • 45. Life-threatening hemorrhagic pneumonia caused by Stenotrophomonas maltophilia in the treatment of hematologic diseases.
    Mori M, Tsunemine H, Imada K, Ito K, Kodaka T, Takahashi T.
    Ann Hematol; 2014 Jun; 93(6):901-11. PubMed ID: 24535696
    [Abstract] [Full Text] [Related]

  • 46.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 47. Stenotrophomonas maltophilia bacteremia in adults: four years' experience in a medical center in northern Taiwan.
    Wang WS, Liu CP, Lee CM, Huang FY.
    J Microbiol Immunol Infect; 2004 Dec; 37(6):359-65. PubMed ID: 15599468
    [Abstract] [Full Text] [Related]

  • 48.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 49. Stenotrophomonas maltophilia bacteremia in children - A 10-year analysis.
    Büyükcam A, Bıçakcıgil A, Cengiz AB, Sancak B, Ceyhan M, Kara A.
    Arch Argent Pediatr; 2020 Jun; 118(3):e317-e323. PubMed ID: 32470274
    [Abstract] [Full Text] [Related]

  • 50.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 51. Clinical characteristics and risk factors for fatality in patients with bloodstream infections caused by glucose non-fermenting gram-negative Bacilli.
    Chang TY, Lee CH, Liu JW.
    J Microbiol Immunol Infect; 2010 Jun; 43(3):233-9. PubMed ID: 21291852
    [Abstract] [Full Text] [Related]

  • 52. Factors associated with mortality in patients with bloodstream infection and pneumonia due to Stenotrophomonas maltophilia.
    Paez JI, Tengan FM, Barone AA, Levin AS, Costa SF.
    Eur J Clin Microbiol Infect Dis; 2008 Oct; 27(10):901-6. PubMed ID: 18483755
    [Abstract] [Full Text] [Related]

  • 53. Clinical Features and Risk Factors for Development of Breakthrough Gram-Negative Bacteremia during Carbapenem Therapy.
    Lee JY, Kang CI, Ko JH, Lee WJ, Seok HR, Park GE, Cho SY, Ha YE, Chung DR, Lee NY, Peck KR, Song JH.
    Antimicrob Agents Chemother; 2016 Nov; 60(11):6673-6678. PubMed ID: 27572416
    [Abstract] [Full Text] [Related]

  • 54. [Bacteraemia at a second level hospital: epidemiological study, analysis of pronostic factors associated to mortality and economic cost estimation].
    Hernández-Roca JJ, García-Vázquez E, Hernández A, Canteras M, Herrero JA, Cascales E, Mené-Fenor E, Gómez-Gómez J.
    Rev Esp Quimioter; 2013 Jun; 26(2):119-27. PubMed ID: 23817650
    [Abstract] [Full Text] [Related]

  • 55. Incidence, risk factors and outcomes of Escherichia coli bloodstream infections in a large Canadian region.
    Laupland KB, Gregson DB, Church DL, Ross T, Pitout JD.
    Clin Microbiol Infect; 2008 Nov; 14(11):1041-7. PubMed ID: 19040476
    [Abstract] [Full Text] [Related]

  • 56. An evaluation of six-year Stenotrophomonas maltophilia infections in a university hospital.
    Ince N, Yekenkurul D, Danış A, Çalışkan E, Akkaş İ.
    Afr Health Sci; 2020 Sep; 20(3):1118-1123. PubMed ID: 33402956
    [Abstract] [Full Text] [Related]

  • 57. Comparisons between patients with trimethoprim-sulfamethoxazole-susceptible and trimethoprim-sulfamethoxazole-resistant Stenotrophomonas maltophilia monomicrobial bacteremia: A 10-year retrospective study.
    Wang CH, Lin JC, Lin HA, Chang FY, Wang NC, Chiu SK, Lin TY, Yang YS, Kan LP, Yang CH, Chan MC, Yeh KM.
    J Microbiol Immunol Infect; 2016 Jun; 49(3):378-86. PubMed ID: 25081988
    [Abstract] [Full Text] [Related]

  • 58. Risk factors for infections with multidrug-resistant Stenotrophomonas maltophilia in patients with cancer.
    Ansari SR, Hanna H, Hachem R, Jiang Y, Rolston K, Raad I.
    Cancer; 2007 Jun 15; 109(12):2615-22. PubMed ID: 17487860
    [Abstract] [Full Text] [Related]

  • 59. Community-acquired infection due to Stenotrophomonas maltophilia: a rare cause of septic arthritis.
    Aydemir C, Aktaş E, Eldeş N, Kutsal E, Demirel F, Ege A.
    Turk J Pediatr; 2008 Jun 15; 50(1):89-90. PubMed ID: 18365601
    [Abstract] [Full Text] [Related]

  • 60.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 26.